# Biogen Inc.: Form 8-K, filed Feb 11, 2026

- Company: [Biogen Inc.](/companies/biib.md) (CIK 875045)
- Form: 8-K
- Filed: 2026-02-11
- Accepted by EDGAR: Feb 11, 2026, 17:07 ET
- Period: 2026-02-11
- Accession: 0001193125-26-046803
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/875045/000119312526046803/d937279d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/875045/000119312526046803/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/875045/000119312526046803/d937279d8k.htm

Filed Feb 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-046803. Last ingested by Listed: Nov 2, 2026, 20:22 ET. No prices; not investment advice.